Abstract:In situ sulfuration of copper hydroxyphosphate nanoparticles by hydrogen sulfide reduces the size of nanoparticles for higher cellular uptake, and enhances the reactive oxygen species (ROS) generation efficiency. The generated ROS can affect the expression of copper transport protein for higher copper accumulation, which in turn activates cuproptosis and induces pyroptosis to maximize the efficiency of cancer therapy. Copper overload is a novel way to achieve copper‐ion‐interference therapy by disrupting copper homeostasis and treating diseases through multiple cell death pathways. However, it is difficult to reach copper overload since excess intracellular copper ions will be pumped out. Herein, copper overload is achieved by both raising cellular uptake and reducing the efflux of copper ions using hydrogen sulfide (H2S)‐responsive copper hydroxyphosphate nanoparticles (Cu2(PO4)(OH) NPs). After immersion in an H2S‐enriched colon cancer microenvironment, Cu2(PO4)(OH) NPs can transform into copper sulfide NPs with reduced size for higher cell entering, resulting in improved Fenton activity as well as copper ion dissociation. Reactive oxygen species generated by the Fenton reaction not only activate inflammasomes and Caspase‐1 proteins, cause the cleavage of gasdermin D to induce pyroptosis, but also affect mitochondrial function and down‐regulate copper exporter ATP7A to further reduce the copper excretion. The combination of higher endocytosis and lower exportation leads to maximized copper overload. Together with the efficient copper ions release, mitochondrial tricarboxylic acid cycle can be disrupted and iron‐sulfur cluster proteins are downregulated, ultimately triggering cuproptosis. As both pyroptosis and cuproptosis are efficient ways to induce cell death, this study provides a novel way to realize effective tumor‐targeted therapy based on H2S‐activated copper overload with simple Cu2(PO4)(OH) NPs.

Copper depletion-induced tumor cuproptosis

Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies

In Situ Sacrificial Growth of Metastable Copper-Enriched Nanomedicine for Cuproptosis-Based Synergistic Cancer Therapy

Regulating Copper Homeostasis of Tumor Cells to Promote Cuproptosis for Enhancing Breast Cancer Immunotherapy

Regenerating Chemotherapeutics through Copper-Based Nanomedicine: Disrupting Protein Homeostasis for Enhanced Tumor Therapy

Cuproptosis and Cuproptosis‐Based Synergistic Therapy for Cancer Treatment

H2S‐Activated Ion‐Interference Therapy: A Novel Tumor Targeted Therapy Based on Copper‐Overload‐Mediated Cuproptosis and Pyroptosis

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance

Dissecting copper biology and cancer treatment: ‘Activating Cuproptosis or suppressing Cuproplasia’

Cuproptosis: Harnessing Transition Metal for Cancer Therapy

Cuproptosis and Serine Metabolism Blockade Triggered by Copper‐Based Prussian Blue Nanomedicine for Enhanced Tumor Therapy

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment

Harnessing nanomaterials for copper-induced cell death

Cuproptosis: emerging biomarkers and potential therapeutics in cancers

Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes

Targeting copper metabolism: a promising strategy for cancer treatment

An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy

Copper homeostasis and cuproptosis in cancer immunity and therapy

Inducing Pyroptosis and Cuproptosis Using Copper Carriers for ROS-Augmented Effective Cancer Therapy

Targeting cuproplasia and cuproptosis in cancer